Pathophysiology of the disturbed angiogenesis in hemophilia.
INTRODUCTION
It has been reported an increase of angiogenesis and vascular remodeling in hemophilic arthropathy. Therefore, antiangiogenic drugs could be useful in the management of hemophilic arthropathy. The aim of this review paper is to revise the role of angiogenesis in hemophilic arthropathy.


AREAS COVERED
This article is a narrative review of the pathophysiology of the disturbed angiogenesis in hemophilia and the potential role of antiangiogenic drugs in nonhemophilia patients Expert commentary: Antiangiogenic drugs could be helpful in the future for the treatment of hemarthroses in hemophilic arthropathy. However, despite some recent reports emphasizing the role of angiogenesis in hemophilia, as these drugs have never been investigated for the treatment of hemophilic arthropathy in PWH, it is clear that they are not indicated.
['Rodriguez-Merchan|E Carlos|EC|']
D020533:Angiogenesis Inhibitors D000818:Animals D006395:Hemarthrosis D006467:Hemophilia A D002836:Hemophilia B D006801:Humans D009389:Neovascularization, Pathologic
angiogenesis Hemophilia hemophilic arthropathy antiangiogenic drugs hemarthrosis